Prasanna N. de Silva
Corresponding Author
Prasanna N. de Silva
Monkwearmouth Hospital, Sunderland, United Kingdom
A B S T R A C T
This article sets out a case for considering generally available polyvalent vaccines such as BCG, MMR and
DPT to be repurposed for treating emerging cognitive decline in elderly people through reducing
neuroinflammation via microglial activation. Up to now, treatments to reduce parenchymal oligomers such
as Amyloid beta in Alzheimer’s disease have been clinically unsuccessful. Therefore, an alternative
approach to try and directly attenuate microglial activation has utility.
Article Info
Article Type
Review Article
Publication history
Received: Tue 21, Jul 2020
Accepted: Wed 12, Aug 2020
Published: Tue 15, Sep 2020
Copyright
© 2023 Prasanna N. de Silva. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Hosting by Science Repository.
DOI:
10.31487/j.NNB.2020.03.08
